Corcept Therapeutics Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $142.6M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $190.8K | 0.1% |
| Other Investing | $24.8M | 17.4% |
| Other Financing | $6.0M | 4.2% |
| Working Capital | $81.7M | 57.3% |
| Other | $30.0M | 21.0% |
| Net Cash Flow | $0 | 0.0% |